drugset / Trial / NCT04532554

Growth Hormone in Obese Cases With Covid-19

NCT04532554

Phase 4 Withdrawn ClinAmygate
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The use of growth hormone in obese cases with COVID-19 may help them to recover earlier.

Timeline

Start
2020-10-26
Primary completion
2020-12-10
Completion
2020-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic

Indications